ACTN4 gene mutations and single nucleotide polymorphisms in idiopathic focal segmental glomerulosclerosis

Nephron - Clinical Practice

Volumn 111, Issue 2, 2009, Pages

  Dai, Shengchuan ^a   Wang, Zhaohui ^a   Pan, Xiaoxia ^a   Chen, Xiaonong ^a   Wang, Weiming ^a   Ren, Hong ^a   Feng, Qi ^b   He, John Cijiang ^c   Han, Bin ^b   Chen, Nan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Chinese Academy of Sciences   (China)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Gene mutations; Idiopathic focal segmental glomerulosclerosis

Indexed keywords

ALPHA ACTININ 4; GENOMIC DNA;

5' UNTRANSLATED REGION; ACTN4 GENE; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HAIR FOLLICLE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KIDNEY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; URINARY EXCRETION;

5' UNTRANSLATED REGIONS; ACTININ; ADOLESCENT; ADULT; AGED; CHILD; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 58149332840     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000191198     Document Type: Article

References (33)

1. Rich AR: A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull John Hopkins Hosp 1957;100:173-186.
2. Barisoni L, Kriz W, Mundel P, et al: The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999;10:51-61.
3. Bahiense-Oliveira M, Saldanha LB, Mota EL, et al: Primary glomerular diseases in Brazil (1979-1999): is the frequency of focal and segmental glomerulosclerosis increasing? Clin Nephrol 2004;61:90-97.
4. Kitiyakara C, Eggers P, Kopp JB: Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis 2004;44:815-825.
5. Barisoni L, Mundel P: Podocyte biology and the emerging understanding of podocyte diseases. Am J Nephrol 2003;23:353-360.
6. Winn MP, Conlon PJ, Lynn KL, et al: A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005;308:1801-1804.
7. Fuchshuber A, Jean G, Gribouval O, et al: Mapping a gene (SRN1) to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis. Hum Mol Genet 1995;4:2155-2158.
8. Mathis BJ, Kim SH, Calabrese K, et al: A locus for inherited focal segmental glomerulosclerosis maps to chromosome 19q13. Kidney Int 1998;53:282-286.
9. Winn MP, Conlon P, Lynn KL, et al: Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. Genomics 1999;58:113-120.
10. Kaplan JM, Kim SH, North KN, et al: Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000;24:251-256.
11. Boute N, Gribouval O, Roselli S, et al: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000;24:349-354.
12. Conlon PJ, Lynn K, Winn MP, et al: Spectrum of disease in familial focal and segmental glomerulosclerosis. Kidney Int 1999;56:1863-1871.
13. Caridi G, Bertelli R, Carrea A, et al: Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol 2001;12:2742-2746.
14. Karle SM, Uetz B, Ronner V, et al: Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 2002;13:388-393.
15. Caridi G, Bertelli R, Di Luca M, et al: Broadening the spectrum of disease related to podocin mutations. J Am Soc Nephrol 2003;14:1278-1286.
16. Weins A, Kenlan P, Herbert S, et al: Mutational and biological analysis of α-actinin-4 in focal segmental glomerulosclerosis. J Am Soc Nephrol 2005;16:3694-3701.
17. Critchley DR: Focal adhesions - the cytoskeletal connection. Curr Opin Cell Biol 2000;12:133-139.
18. El-Husseini AE, Kwasnicka D, Yamada T, et al: BERP, a novel ring finger protein, binds to α-actinin-4. Biochem Biophys Res Commun 2000;267:906-911.
19. Patrie KM, Drescher AJ, Welihinda A, et al: interaction of two actin-binding proteins, synaptopodin and α-actinin-4, with the tight junction protein MAGI-1. J Biol Chem 2002;227:30183-30190.
20. Dandapani SV, Sugimoto H, Matthews BD, et al: α-Actinin-4 is required for normal podocyte adhesion. J Biol Chem 2007;282:467-477.
21. Menez J, Le Maux Chansac B, Dorothee G, et al: Mutant α-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinoma. Oncogene 2004;23:2630-2639.
22. Kos CH, Le TC, Sinha S, et al: Mice deficient in α-actinin-4 have severe glomerular disease. J Clin Invest 2003;111:1683-1690.
23. Michaud JL, Lemieux LI, Dube M, et al: Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant α-actinin-4. J Am Soc Nephrol 2003;14:1200-1211.
24. Yao J, Le TC, Kos CH, et al: α-Actinin-4-mediated FSGS:an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein. PLOS Biol 2004;2:0788-0794.
25. Michaud JL, Chaisson KM, Parks RJ, et al: FSGS-associated α-actinin-4 (K256E) impairs cytoskeletal dynamics in podocytes. Kidney Int 2006;70:1054-1061.
26. Weins A, Schlondorff JS, Nakamura F, et al: Disease-associated mutant α-actinin-4 reveals a mechanism for regulating its F-actin-binding affinity. Proc Natl Acad Sci USA 2007;104:16080-16085.
27. Komatsuda A, Wakui H, Maki N, et al: Analysis of mutations in α-actinin-4 and podocin genes of patients with chronic renal failure due to sporadic focal segmental glomerulosclerosis. Ren Fail 2003;25:87-93.
28. Aucella F, De Bonis P, Gatta G, et al: Molecular analysis of NPHS2 and ACTN4 genes in a series of 33 Italian patients affected by adult-onset nonfamilial focal segmental glomerulosclerosis. Nephron Clin Pract 2005;99:31-36.
29. Schmid H, Henger A, Cohen CD, et al: Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol 2003;14:2958-2966.
30. Salowsky R, Heiss NS, Benner A, et al: Basal transcription activity of the dyskeratosis congenita gene is mediated by Sp1 and Sp3 and a patient mutation in a Sp1-binding site is associated with decreased promoter activity. Gene 2002;293:9-19.
31. Kole R, Williams T, Cohen L: RNA modulation, repair and remodeling by splice switching oligonucleotides. Acta Biochim Pol 2004;51:373-378.
32. Melo KF, Martin RM, Costa EM, et al:An unusual phenotype of Frasier syndrome due to IVS9 + 4C>T mutation in the WT1 gene: predominantly male ambiguous genitalia and absence of gonadal dysgenesis. J Clin Endocrinol Metab 2002;87:2500-2505.
33. Denamur E, Bocquet N, Mougenot B, et al: Mother-to-child transmitted WT1 splice-site mutation is responsible for distinct glomerular diseases. J Am Soc Nephrol 1999;10:2219-2223.